Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose amoxicillin + esomeprazole dual therapy vs bismuth quadruple therapy for H. pylori eradication
ChiCTR2000033759Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin and esomeprazole in Helicobacter pylori infection (2 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoint: Eradication rate. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
amoxicillinesomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2000033759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033759.